vTv Therapeutics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -0.1596 | -100% |
| P/S |
|
2082.66 | 33.44 | 6128.91% |
|
|
| P/BV |
|
-1.01 | 4.64 | -121.76% |
|
|
| P/FCF |
|
0 | 42.53 | -100% |
|
|
| Ev/Ebitda |
|
-0.3867 | -17.68 | -97.81% |
|
|
| Ev/S |
|
1091.88 | 22.59 | 4732.51% |
|
|
| Ev/FCF |
|
-0.5308 | 47.55 | -101.12% |
|
|
| E/P |
|
0 | 0.0182 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-282355.56 | -14.2 | 1987795.12% | -113313.35 | +149.18% |
| ROE |
|
82.05 | 9.78 | 738.73% |
|
|
| ROA |
|
-183.79 | 0.33 | -55785.76% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-225000 | -26.41 | 851726.61% |
|
|
| ROCE |
|
137.48 | 14.55 | 844.95% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0208 | -3.87 | -99.46% | -0.0289 | -27.87% |
| Nеt Debt/Ebitda |
|
0.3509 | -4.24 | -108.27% |
|
|
| Debt/Ratio |
|
0.048 | 0.1853 | -74.09% |
|
|
| Debt/Equity |
|
2.56 | 1.61 | 59.08% |
|
|
| Debt/Net Income |
|
-0.0261 | 10.06 | -100.26% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2368 | -100% |
|
|
| Average dividend growth |
|
0 | 1.48 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4863 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-99.68 | 30.62 | -425.54% | ||
| Growth impulse Ebitda in 5 years |
|
27.06 | -17.42 | -255.34% | ||
| Growth impulse Net Income in 5 years |
|
-7.53 | -52.26 | -85.59% | ||
| Growth impulse FCF in 5 years |
|
-17.4 | -31.68 | -45.08% | ||
| Growth impulse EPS in 5 years |
|
1241.12 | -61.82 | -2107.64% |
IP Score
3.58/10
